Key result
Metastatic prostate adenocarcinoma linked to pulmonary tumor thrombotic microangiopathy in only the second reported case.
This case report highlights metastatic prostate adenocarcinoma as a rare but possible cause of pulmonary tumor thrombotic microangiopathy.
May warrant including prostate adenocarcinoma in the differential for pulmonary tumor thrombotic microangiopathy; extends sparse case reports but remains hypothesis-generating.
Pulmonary tumor thrombotic microangiopathy is a rare but serious malignancy-related respiratory complication. The most common causative neoplasm is gastric adenocarcinoma. We report a case caused by metastatic prostate adenocarcinoma, diagnosed postmortem in a 58-year-old male. To our knowledge, this is the second reported case from metastatic prostate adenocarcinoma.
No takes yet. Share an insight, caveat, or question.
Nayyar et al. (2015) studied this question. Metastatic prostate adenocarcinoma can cause pulmonary tumor thrombotic microangiopathy, representing only the second reported case of this specific etiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: